Obesity Implicated in One in Six UK Deaths from Infectious Diseases
New research has revealed a stark connection between obesity and mortality from infectious diseases, with obesity driving approximately one in six such deaths in the United Kingdom. The study, published in the Lancet medical journal, indicates that globally, obesity may have been a contributing factor in 0.6 million out of 5.4 million deaths from infectious diseases in 2023. In the UK specifically, it accounted for 7,300 out of 42,000 deaths in that year, highlighting a significant public health concern.
Global and UK-Specific Findings on Obesity and Infection Mortality
The research, which analysed data from over 540,000 individuals in Finland and the UK, including more than 470,000 adults from the UK Biobank dataset, followed participants for an average of 13 to 14 years. By examining risk estimates from 925 bacterial, viral, parasitic, and fungal infectious diseases, researchers found that obesity was linked to one in ten infection-related deaths worldwide in 2023. However, the impact is more pronounced in the UK, where nearly a third of adults are classified as obese, increasing their vulnerability to severe outcomes from infections.
Mechanisms Behind Increased Risk and Health Implications
Professor Naveed Sattar, a co-author of the study from the University of Glasgow, explained that obesity can compromise the body's defences against infections in multiple ways. "It can affect how well the immune system works – for instance, by altering the gut microbiome, limiting how fully the lungs expand, and even changing how much virus a person is exposed to," he stated. Additionally, obesity stretches tissues, reducing blood flow to the skin and making infections more likely, while skin folds can create hygiene challenges. Experts warn that people with obesity are 70% more likely to be hospitalised or die from an infectious disease, with those having severe obesity facing three times the risk.
The study also noted that this increased risk is not solely due to obesity-related chronic conditions like type 2 diabetes, as the link to severe infections was observed in patients both with and without such conditions. Professor Mika Kivimaki, who led the research from University College London, emphasised, "Our findings suggest that obesity weakens the body’s defences against infections, resulting in more serious diseases. People may not get infected more easily, but recovery from infection is clearly harder."
Potential Solutions and Policy Recommendations
In response to these findings, experts are advocating for urgent policy measures to support weight management and improve public health. Weight loss drugs, currently used by an estimated 1.6 million people in the UK, are suggested as a potential tool to mitigate the health risks associated with obesity. Professor Sattar highlighted that large-scale trials show these medications can meaningfully reduce deaths from infections compared to placebos. Dr Earim Chaudry, an NHS GP and chief medical officer at an online obesity clinic, added that weight loss injections can have positive effects on blood sugar levels, cholesterol, and cardiorespiratory health, beyond just weight reduction.
The study authors conclude that there is a critical need for enhanced weight-management services and broader access to effective treatments. As obesity levels continue to rise, the trend of increased infection-related mortality is expected to worsen, underscoring the importance of proactive health strategies and interventions.
